An integrated clinical microbiology service ensures optimal early empirical antimicrobial therapy for methicillin-resistant Staphylococcus aureus bloodstream infection

Infect Control Hosp Epidemiol. 2010 Sep;31(9):981-2; author reply 983. doi: 10.1086/656207.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Cross Infection / drug therapy
  • Cross Infection / microbiology*
  • Hospital Bed Capacity, 500 and over
  • Humans
  • Ireland
  • Methicillin-Resistant Staphylococcus aureus / drug effects
  • Methicillin-Resistant Staphylococcus aureus / isolation & purification*
  • Staphylococcal Infections / drug therapy
  • Staphylococcal Infections / microbiology*
  • Time Factors
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents